Work

Abstract 1559: First-in-class Zα-domain-targeted ADAR1 p150 inhibitor demonstrates potent antitumor efficacy in high IFN syngeneic melanoma

Year: 2026
Type: conference-abstract
Language: English
Open Access status: closed
OpenAlex ID: W7148847540
Cites:
Cited by:
Related to: